| |
NEWLY AVAILABLE, NEWLY APPROVED
Shoe Selection System
OPIS™, the Internet-based Optimal Performance Index System, has announced the availability to the medical and athletic communities of its comparative analysis of athletic shoes. Created by a team of sports medicine professionals, OPIS is the first patented system to provide scientific analysis of the most relevant features of athletic shoes, including torsion control, vertical compression, and fatigue factor.
OPIS provides shoe recommendations in a simple, comprehensive format. Customers traditionally have had to primarily rely on shoe descriptions from the manufacturer or subjective user evaluations. OPIS’s objective, comparative system for testing how a shoe actually functions is based on a consistent unbiased methodology. These aspects of shoe stability indicate how well biomechanical movement is controlled during running, and more stable shoes are associated with lower injury rates according to clinical studies. Shoes are ranked, indexed, and entered into the OPIS database to provide a resource for medical professionals to make objective, accurate recommendations to patients and clients.
OPIS objectively tests and ranks shoes against each other. This unbiased data is then compiled into a web-based interactive index system that allows users to enter their unique athletic profile, including their gender, gait, stature, and injury history. Once a person’s profile is entered, OPIS identifies the best possible shoes to fit his or her needs, thereby improving performance and hastening rehabilitation.
The OPIS database is easy to use and available at 3 subscription levels.
For more information, visit
www.opistest.com
|
Subtle Cavus Orthotic
dj Orthopedics, Inc. has announced the release of the DonJoy® ArchRival™, a patented, pre-fabricated foot orthotic for the treatment of subtle cavus foot.
DonJoy's ArchRival is constructed with a reduced medial arch and recessed area under the first metatarsal head to accommodate the plantar-flexed first ray. An incorporated elevated heel allows for shock absorption and accommodation of tight calf musculature, often seen with subtle cavus foot. In addition, each ArchRival is designed with X-Static Technology, silver-coated fibers woven into the surface layer of fabric to assist in the prevention of pathogens, blisters, and odors. The ArchRival is available in 7 sizes and is designed to fit in most types of athletic and walking shoes.
For more information, contact
djorthopedics
2985 Scott Street
Vista, CA 92801
Phone (800)
321-9549
Fax (760)734-3595
www.djortho.com
|
Electrical Stimulation Device
| Hanger Orthopedic Group, Inc. has announced its wholly owned subsidiary Innovative Neurotronics, Inc. received 510(k) clearance from the U.S. Food and Drug Administration to treat patients with the WalkAide System®.
The first of Innovative Neurotronics, Inc.’s line of functional electrical stimulation products, the WalkAide System is designed to counter the lack of ankle dorsiflexion, or foot drop, in patients who have sustained damage to upper motor neurons or pathways to the spinal cord. Using functional electrical stimulation, the WalkAide System stimulates the common peroneal nerve as it passes near the head of the fibula. This stimulation activates the muscles that dorsiflex the foot at the appropriate time during the gait cycle, producing a natural and efficient walking pattern with increased stability. In addition to improving the patient’s gait, the WalkAide System may provide patients with increased mobility, prevention/retardation of disuse atrophy, increased local blood flow, muscle re-education, and maintained or increased joint range of motion.
To learn more, contact
Innovative Neurotronics, Inc.
2 Bethesda Metro Center, 12th Floor
Bethesda, MD 20814
www.walkaide.com
|
Medial Knee
Implant
| Advanced Bio-Surfaces, Inc., an orthopedic implant developer and manufacturer, announced in February that it has received 510(k) clearance to market from the FDA for its OrthoGlide® Medial Knee Implant.
The OrthoGlide implant is composed of cobalt-chrome alloy intended to replace some of the cartilage functions that have been lost as a result of osteoarthritis. The implant is engineered to provide positional stability without the use of rigid fixation methods. In addition, the specially contoured geometry of the implant provides an open glide path, allowing for the unconstrained motion of the femoral condyle.
For more information, contact
Advanced Bio-Surfaces
5909 Baker Road, Suite
550
Minnetonka, MN 55354
Phone (952)912-5400
www.advbiosurf.com
|
Soft-Tissue ACL Reconstruction
Fixation System
| Scandius BioMedical, Inc. announced that the TriTis Tibial Fixation System has been granted 510(k) market clearance by the FDA and has been used successfully in anterior cruciate ligament (ACL) reconstruction. The new TriTis Tibial Fixation System is designed to
provide strength in 3 ways: a cleat for tissue compression in the
tunnel, an off-axis fixation screw to anchor the device, and a fixation washer to capture graft limbs,
preventing graft slippage.
Scandius BioMedical reports that in early clinical use, the TriTis product has produced excellent clinical outcomes. TriTis was developed to address the problem of fixation strength in the tibia, where stronger fixation is needed to hold a soft-tissue graft in place. As a result, the TriTis tibial fixation implant has been designed to provide a stronger and stiffer construct. The company points out that the tibial fixation system can be used in conjunction with the Stratis™ ST Femoral Fixation, providing a complete solution for reconstruction of the ACL.
To learn more, contact
Scandius BioMedical
11A Beaver Brook Road
Littleton, MA 01460
Phone (978)486-4088
fax (978) 486-4108
www.scandius.com
|
Ceramic Spinal Implant System
| Amedica Corporation announced clearance from the FDA for market distribution of its Arx™ Ceramic Spinal Spacer System™.
The Arx Ceramic Spinal Spacer System provides biocompatible implants based on Amedica’s patented MC2™ technology that offers physicians and patients an alternative to other synthetic and allograft bone implants used for the restoration of spinal anatomy.
Amedica’s Arx spinal implants are designed as vertebral body replacements for use in the thoraco-lumbar region of the spine to replace collapsed, damaged, or unstable vertebral bodies resulting from such causes as degenerative disease and/or trauma. These spinal implants are designed to combine strength, imaging clarity, and bio-mimetic characteristics. Amedica anticipates that surgeons using its ceramic spinal implants will appreciate the ease of use, reproducibility, and predictability provided by its products in spinal procedures.
To learn more, contact
Amedica
615 Arapeen Drive, Suite 302
Salt Lake City, UT
phone (801)583-5100
fax (801)583-8635
www.amedicacorp.com
|
|
